目的 分析25-羟基维生素D(25-OH-VD)、骨钙素(BGP)以及抗酒石酸酸性磷酸酶(TRACP-5b)联合检查在骨质疏松临床诊疗中的作用. 方法 选择由英国IDS公司制造的试剂盒,借助酶联免疫法(ELISA)针对患者开展血清(25-OH-VD)检测,同时给予BGP检测和TRACP-5b检测. 结果 女患TRACP-5b检测结果为(5.71±2.46) u/L,高于男患的(4.98±1.61)u/L(P<0.05). 结论 针对骨质疏松,同时实施25-OH-VD检测、BGP检测以及TRACP-5b检测能够发挥良好应用效果.%Objective to analyze 25 a 25-hydroxyitamin D (25 - OH - VD), osteocalcin (BGP) and tartrate resistant acid phosphatase (TRACP 5 b) joint inspection role in clinical diagnosis and treatment of osteoporosis. Methods The choice made by the British IDS company kit, using enzyme-linked immunoassay (ELISA) for patients in serum (25-OH-VD) de-tection, while giving BGP detection and TRACP 5 b. Results Women with TRACP 5 b test results for soil (5.71±5.71) u/L, higher than that of male with soil(4.98±4.98) u/L(P<0.05). Conclusion In view of the osteoporosis, at the same time, the im-plementation of 25-OH-detecting VD, BGP and TRACP 5 b detection can play a good application effect.
展开▼
